Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
BT-474
HER2amp
Luminal
Purvalanol A
CDK1
CDK
5906.067
uM
inf
inf
0.9890 0.9890 0.0000 -0.0331
-0.7588
0.6838
CAMA-1
HR+
Luminal
Baicalein
Lipoxygenase
Metabolism
10755.072
uM
inf
inf
0.2784 0.2784 0.0000 0.2357
0.5071
0.7300
600MPE
HR+
Luminal
Dactolisib
PI3K
PI3K
12224.155
uM
inf
inf
0.7744 0.7744 0.0000 0.1982
0.2284
1.0378
BT-474
HER2amp
Luminal
Selumetinib
MEK
MAPK
12178.155
uM
inf
inf
0.7564 0.7564 0.0000 0.1748
0.0109
0.8489
BT-20
TNBC
Basal A
Methotrexate
DHFR
Metabolism
5904.085
uM
inf
inf
1.0500 1.0500 0.0000 -0.0334
-1.4110
1.2247
BT-474
HER2amp
Luminal
FTase Inhibitor I
Ftase
MAPK
12056.154
uM
inf
inf
0.7002 0.7002 0.0000 0.2152
-0.1183
0.9136
600MPE
HR+
Luminal
Glycyl-H-1152
ROCK2
12224.16
uM
inf
inf
0.9729 0.9729 0.0000 0.0688
0.1842
0.7734
600MPE
HR+
Luminal
2-deoxyglucose
13091.177
uM
inf
inf
0.9504 0.9504 0.0000 0.3143
0.0580
0.7004
AU565
HER2amp
Luminal
Selumetinib
MEK
MAPK
10880.155
uM
inf
inf
1.0500 1.0500 0.0000 -0.0108
-0.1312
1.5205
AU565
HER2amp
Luminal
Sorafenib
PDGFR/VEGFR/KIT/FLT3
RTK
5900.085
uM
inf
inf
0.5199 0.5199 0.0000 0.0667
0.2964
2.6391
BT-20
TNBC
Basal A
Pertuzumab
5903.102
mg/ml
inf
inf
0.9324 0.9324 0.0000 -0.0074
-0.0405
1.2557
600MPE
HR+
Luminal
AG1024
IGF1R
RTK
5898.066
uM
inf
inf
1.0423 1.0423 0.0000 0.0282
0.0610
0.6097
600MPE
HR+
Luminal
AG1024
IGF1R
RTK
5899.066
uM
inf
inf
1.0500 1.0500 0.0000 0.0165
0.0780
0.7056
600MPE
HR+
Luminal
PS-1145
IKK
NFKB
5899.065
uM
inf
inf
0.8491 0.8491 0.0000 0.1182
0.0000
1.0946
BT-483
HR+
Luminal
PD184352
MEK
MAPK
11855.155
uM
inf
inf
0.7132 0.7132 0.0000 0.3205
0.0000
0.7873
AU565
HER2amp
Luminal
PS-1145
IKK
NFKB
5900.065
uM
inf
inf
0.9321 0.9321 0.0000 -0.0050
0.3225
2.2026
600MPE
HR+
Luminal
Baicalein
Lipoxygenase
Metabolism
12224.072
uM
inf
inf
0.8349 0.8349 0.0000 0.1299
-0.0188
1.0105
AU565
HER2amp
Luminal
Cetuximab
EGFR
ErbB
9035.018
uM
inf
inf
0.9083 0.9083 0.0000 0.0297
0.4162
2.1555
BT-474
HER2amp
Luminal
GSK461364
PLK1
PLK
7798.001
uM
inf
inf
0.2083 0.2083 0.0000 0.2423
0.3086
1.3667
BT-474
HER2amp
Luminal
Glycyl-H-1152
ROCK2
12291.169
uM
inf
inf
0.8955 0.8955 0.0000 -0.0374
0.1290
0.3548
AU565
HER2amp
Luminal
PS-1145
IKK
NFKB
5901.065
uM
inf
inf
0.9807 0.9807 0.0000 0.0027
-0.0002
2.0114
BT-483
HR+
Luminal
Lapatinib
EGFR/HER2
ErbB
5908.098
uM
inf
inf
0.7516 0.7516 0.0000 0.2163
-0.0860
0.6091
BT-474
HER2amp
Luminal
Cetuximab
EGFR
ErbB
7798.018
uM
inf
inf
1.0028 1.0028 0.0000 -0.0260
-0.7402
1.4461
HCC1187
TNBC
Basal A
Cetuximab
EGFR
ErbB
7811.018
uM
inf
inf
0.6946 0.6946 0.0000 0.1308
-0.0060
0.4694
HCC1187
TNBC
Basal A
Celecoxib
COX2
COX
10518.136
uM
inf
inf
0.9091 0.9091 0.0000 0.0220
0.1805
1.2490